Progress in neuroprotective strategies for preventing epilepsy.

Area of Science:

• Neuroscience
• Epileptology
• Regenerative Medicine

Background:

• Temporal lobe epilepsy (TLE) develops after an initial precipitating injury (IPI), involving neurodegeneration and brain reorganization.
• This process, known as epileptogenesis, leads to chronic epilepsy with seizures and cognitive deficits.
• Neuroprotection is a key therapeutic area for managing TLE.

Purpose of the Study:

• To review current knowledge on neuroprotection in epilepsy.
• To evaluate the efficacy of various neuroprotective strategies for chronic TLE.
• To identify gaps in research and future directions for TLE treatment.

Main Methods:

• Review of existing literature on neuroprotection and TLE.
• Analysis of conventional and novel anti-epileptic drugs.
• Evaluation of alternative therapies including ketogenic diet, neurotrophic factors, hormones, antioxidants, and cell grafting.

Main Results:

• Conventional anti-epileptic drugs offer primary neuroprotection but are limited in preventing chronic TLE development.
• Alternative strategies like ketogenic diet, neurotrophic factors, hormones, and antioxidants show potential for preventing and treating chronic TLE.
• Fetal hippocampal cell grafting is promising but faces challenges in cell availability, ethics, and timing.

Conclusions:

• Neuroprotective strategies must be applied promptly after an IPI for maximum benefit.
• While promising, long-term efficacy and optimal timing for alternative therapies require further investigation.
• Developing ideal strategies for brain repair and preventing TLE evolution remains a critical challenge.